Saudi Food and Drug Authority (SFDA) CEO Dr. Hisham Aljadhey yesterday visited a factory here:audi Food and Drug Authority (SFDA) CEO Dr. Hisham Aljadhey yesterday visited a factory here, while on a visit to China, where he was briefed on advanced manufacturing technologies used for the production of biological and genetic medicines. He also visited the Institute of Hematology and Blood Diseases Hospital in Tianjin, a facility renowned for its treatment of blood disorders.

According to Saudi Press Agency, the hospital, which boasts a capacity of 1,000 beds and is equipped with the latest technologies and advanced laboratories, conducts both research and clinical studies. Aljadhey was told about the ongoing clinical trials and the application of genetic medicines in cancer therapy. The hospital plays a key role in medical innovation, developing novel treatments and personalized therapeutic regimens based on genetic medicine, thus providing effective solutions to treat cancer and various blood diseases.

The v
isit is done with the goal of improving the quality and safety of imported medicines and reflects the broader aim of strengthening international cooperation and sharing experience in the health sector. It underscores SFDA’s commitment to improving the quality of therapeutic techniques used in Saudi Arabia, ultimately raising healthcare standards for the community, and to promoting global collaboration.

While in China, Aljadhey will lead the Saudi delegation to the 8th Shenzhen Food Safety Forum, which will be held on November 5-6.